Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas
Authors:
Open Access
- 20 June 2003
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 122 (1) , 70-77
Abstract
Summary. Natural killer (NK) cell lymphomas lack suitable clonal markers for tumour cell detection, making the monitoring of minimal residual lymphoma difficult. Aberrant promoter CpG methylation occurs frequently in NK cell lymphomas. The objective of this study was to assess the potential of aberrant methylation as a surrogate tumour marker. Twenty‐five primary tumours and 105 serial biopsies taken at various time points after treatment were examined using a methylation‐specific polymerase chain reaction (MSP) for a panel of genes, comprising p73, p16, hMLH1, RARβ and p15, previously shown to be methylated in NK cell lymphomas. All samples underwent independent morphological examination, supplemented by immunostaining for CD56 and in‐situ hybridization for Epstein–Barr‐virus‐encoded RNA. Primary tumours showed the frequent methylation of the genes p73 (92%), p16 (71%), hMLH1 (61%), RARβ (56%) and p15 (48%). MSP results in serial post‐treatment biopsies were correlated with clinicopathological findings. Results were concordant in 89 follow‐up samples (18 samples, histology positive/MSP positive; 71 samples, histology negative/MSP negative) and discordant in 16. Fifteen samples were histology negative/MSP positive, and tumour involvement was subsequently confirmed (positive re‐biopsies or relapses at the same sites), indicating that MSP was more sensitive for minimal lymphoma detection. One sample was histology positive/MSP negative; a subsequent histological review and continuous clinical remission of the patient did not support tumour involvement. Our findings suggest that MSP for aberrantly methylated genes is a potentially valuable molecular marker for detecting either residual or relapsed disease in NK cell lymphoma patients.Keywords
This publication has 15 references indexed in Scilit:
- Sinonasal NK/T-cell Lymphomas in the United StatesAmerican Journal of Surgical Pathology, 2000
- Aberrant Methylation of Gene Promoters in Cancer--Concepts, Misconcepts, and PromiseJNCI: Journal of the National Cancer Institute, 2000
- DNA hypermethylation in tumorigenesis: epigenetics joins geneticsTrends in Genetics, 2000
- CpG island methylator phenotype in colorectal cancerProceedings of the National Academy of Sciences, 1999
- Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung CancerJNCI: Journal of the National Cancer Institute, 1999
- Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.Journal of Clinical Oncology, 1998
- CD56+ NK lymphomas:clinicopathological features and prognosisBritish Journal of Haematology, 1997
- Autologous bone marrow transplantation for primary nasal T/NK cell lymphomaBone Marrow Transplantation, 1997
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell LymphomasAmerican Journal of Surgical Pathology, 1996